Inhibition of anandamide hydrolysis: Cells also know how to do it

Trends in Molecular Medicine

Volumn 10, Issue 1, 2004, Pages 13-14

  MacCarrone, Mauro ^a,b  

^a UNIVERSITY OF TERAMO   (Italy)

^b C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANANDAMIDE; ANXIOLYTIC AGENT; CYCLOHEXYLCARBAMIC ACID 3' CARBAMOYLBIPHENYL 3 YL ESTER; UNCLASSIFIED DRUG;

ANXIETY DISORDER; CELL ACTIVITY; DRUG ACTIVITY; DRUG BIOAVAILABILITY; DRUG MECHANISM; DRUG TARGETING; EMOTION; HYDROLYSIS; IC 50; INHIBITION KINETICS; LETTER; OXIDATION; PROTEIN TARGETING;

EID: 0742287053     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmed.2003.11.008     Document Type: Letter

References (10)

1. Maccarrone M., Finazzi-Agricò A. Endocannabinoids and their actions. Vitam. Horm. 65:2002;225-255.
2. Bracey M.H., et al. Structural adaptations in a membrane enzyme that terminates endocannabinoid signaling. Science. 298:2002;1793-1796.
3. Mechoulam R., et al. Cannabinoids and brain injury: therapeutic implications. Trends Mol. Med. 8:2002;58-61.
4. Bisogno T., et al. Fatty acid amide hydrolase, an enzyme with many bioactive substrates. Possible therapeutic implications. Curr. Pharm. Des. 8:2002;533-547.
5. Cravatt B.J., Lichtman A.H. Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system. Curr. Opin. Chem. Biol. 7:2003;469-475.
6. Kathuria S., et al. Modulation of anxiety through blockade of anandamide hydrolysis. Nat. Med. 9:2003;76-817.
7. Gaetani S., et al. Anandamide hydrolysis: a new target for anti-anxiety drugs? Trends Mol. Med. 28:2003;474-478.
8. Van der Stelt M., et al. Oxygenated metabolites of anandamide and 2-arachidonoylglycerol: conformational analysis and interaction with cannabinoid receptors, membrane transporter and fatty acid amide hydrolase. J. Med. Chem. 45:2002;3709-3720.
9. Veldhuis W.B., et al. Neuroprotection by the endogenous cannabinoid anandamide and arvanil against in vivo excitotoxicity in the rat: role of vanilloid receptors and lipoxygenases. J. Neurosci. 23:2003;4127-4133.
10. Kozak K.R., et al. 15-Lipoxygenase metabolism of 2-arachidonoylglycerol. Generation of a peroxisome proliferator-activated receptor α agonist. J. Biol. Chem. 277:2002;23278-23286.